Latest News about TEVA
Recent news which mentions TEVA
2 Biotech Stocks That Could Soar in the Third Quarter
July 02, 2022
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
May 11, 2022
From Benzinga
Teva's Q1 Results: Is the Stock About to Crash?
May 05, 2022
From Motley Fool
From Benzinga
Tickers
TEVA
From Motley Fool
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
May 03, 2022
Tickers
TEVA
From Benzinga
From Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From MarketWatch
Is Teva Pharmaceuticals a Brilliant Contrarian Pick?
April 21, 2022
From Motley Fool
From Benzinga
From Benzinga
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
April 20, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.